Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SYNTARA LIMITED Director's Dealing 2023

Oct 2, 2023

65830_rns_2023-10-02_bf981983-59e7-4f83-9633-530e040f91bc.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Appendix 3Z Final Director’s Interest Notice

Rule 3.19A.3

Appendix 3Z

Final Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity PHARMAXIS LTD ABN 75 082 811 630

We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of director Dr Neil Graham
Date of last notice 2 December 2022
Date that director ceased to be director 3 October 2023

Part 1 – Director’s relevant interests in securities of which the director is the registered holder In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Number & class of securities

Not applicable

  • See chapter 19 for defined terms.

11/3/2002

Appendix 3Z Page 1

Appendix 3Z Final Director’s Interest Notice

Part 2 – Director’s relevant interests in securities of which the director is not the registered holder

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Name of holder & nature of interestNote: Provide details of the circumstances giving rise tothe relevant interestBiopharmaMedicinesPharmaLLC, a company of which DrGraham is a director and has abeneficial interest. Number & class of securities3,000,000 options over ordinary shares

Part 3 – Director’s interests in contracts

Detail of contract Not applicable
Nature of interest
Name of registered holder(if issued securities)
No. and class of securities towhich interest relates
  • See chapter 19 for defined terms.

Appendix 3Z Page 2

11/3/2002